Eastwood Bio-Medical Company Insiders

Eastwood Bio-Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.6415) % which means that it has lost $0.6415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.4716) %, meaning that it generated substantial loss on money invested by shareholders. Eastwood Bio-Medical's management efficiency ratios could be used to measure how well Eastwood Bio-Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 0.85 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.22). At this time, Eastwood Bio-Medical's Non Current Assets Total are fairly stable compared to the past year. Asset Turnover is likely to climb to 1.21 in 2024, whereas Total Assets are likely to drop slightly above 418.2 K in 2024. Common Stock Shares Outstanding is likely to drop to about 71.5 M in 2024. Net Loss is likely to drop to about (141.6 K) in 2024

Eastwood Bio-Medical Workforce Comparison

Eastwood Bio-Medical Profit Margins

The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.

Eastwood Bio Medical Benchmark Summation

Eastwood Bio-Medical Notable Stakeholders

The success or failure of an entity such as Eastwood Bio Medical often depends on how effective the management is. Eastwood Bio-Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Eastwood management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Eastwood management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Eastwood Bio-Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Eastwood Bio Medical Canada. Check Eastwood Bio-Medical's Beneish M Score to see the likelihood of Eastwood Bio-Medical's management manipulating its earnings.

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.